Albert Do

Albert Do is an Assistant Professor of Medicine (Digestive Diseases) at Yale University School of Medicine. He serves as the Clinical Director of the Yale University Fatty Liver Disease Program. His expertise lies in hepatology, obesity medicine, metabolic health, and gastroenterology, with a focus on fatty liver diseases including nonalcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease. Dr. Do completed his undergraduate studies at the University of California, Berkeley, followed by an MD and MPH from Boston University. He trained at Yale University for his residency and fellowship.

Education

• Bachelor's Degrees in Molecular and Cell Biology and Psychology, University of California, Berkeley (2006)
• MD, Boston University School of Medicine (2012)
• MPH in Epidemiology, Boston University School of Public Health (2012)
• Residency and Fellowship in Gastroenterology at Yale University School of Medicine (2015)

Research Interests

Dr. Do’s research focuses on clinical and epidemiological studies of fatty liver diseases using large databases. He investigates the impact of metabolic dysfunction, alcohol use, and comorbidities (e.g., HIV, psychiatric disorders) on liver and cardiovascular outcomes. His work emphasizes integrated weight management strategies and precision medicine approaches to improve NAFLD/MAFLD care.

Publications & Awards

• Recipient of the Samuel Kushlan Award for Excellence in Research (Yale School of Medicine, 2019)
• AGA Young Investigator Award (2016)
• AASLD Emerging Liver Scholar Award (2013)

Advising & Grants

Dr. Do collaborates with researchers such as Wajahat Mehal, Joseph Lim, and Andrew Duffy on clinical trials and observational studies. He leads the Metabolic Interventions to Resolve NASH (MIRNA) trial. His work bridges hepatology and obesity medicine, advocating for multidisciplinary approaches to metabolic liver diseases.

Labs & Teams

He directs the Yale Fatty Liver Disease Program, integrating metabolic and hepatology care to address NAFLD, NASH, and related conditions.